A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.

A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can continue among the Trump administration's freeze on HHS activities.

NIH Acting Director: Matthew Memoli ... regulation, public health preparedness, and data analytics on the front lines of the ...

National Institutes of Health (NIH) Director Monica Bertagnolli will resign on Jan. 17, she told staff this week, ending her tenure as the head of the $48 billion biomedical research agency after ...

Many public health experts supported mandates for ... scientific community,” Dr. Ned Sharpless, who served as director of the National Cancer Institute from 2017 to 2022, told CNN in an ...

The current director of the National Institutes of Health, Monica M. Bertagnolli, M.D., has announced that she will step down from the position ...

The director of the National Institutes of Health, Dr. Monica Bertagnolli, announced that she will step down Friday, 14 months after she took the position on Nov. 9, 2023. Bertagnolli began her ...

FRIDAY, Jan. 17, 2025 (HealthDay News) -- The current director of the National Institutes of Health, Monica M. Bertagnolli, M.D., has announced that she will step down from the position on Friday ...